In this issue, guest editors bring their considerable expertise to this important topic. Contains 16 practice-oriented topics including fibroblast activation protein inhibitor (FAPI) PET imaging in pancreatic cancer; fibroblast activation protein inhibitor (FAPI) PET imaging in colorectal cancer; fibroblast activation protein inhibitor (FAPI) cardiac imaging; fibroblast activation protein inhibitor (FAPI) PET/CT in gastric cancer; and more. Provides in-depth clinical reviews on fibroblast activation protein imaging, offering actionable insights for clinical practice. Presents the latest…mehr
In this issue, guest editors bring their considerable expertise to this important topic. Contains 16 practice-oriented topics including fibroblast activation protein inhibitor (FAPI) PET imaging in pancreatic cancer; fibroblast activation protein inhibitor (FAPI) PET imaging in colorectal cancer; fibroblast activation protein inhibitor (FAPI) cardiac imaging; fibroblast activation protein inhibitor (FAPI) PET/CT in gastric cancer; and more. Provides in-depth clinical reviews on fibroblast activation protein imaging, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Advanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor Imaging Fibrosis Cardiac Applications of Fibroblast Activation Protein Imaging Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions
Advanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor Imaging Fibrosis Cardiac Applications of Fibroblast Activation Protein Imaging Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497